Anticancer Drugs Market Expected to Witness Robust Growth | Novartis AG, Pfizer Inc, Bayer AG

Global Anticancer Drugs Market Size study, By Drug Type – Cytotoxic Drugs (Alkylating Agents, and Antimetabolites), Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors), and Hormonal Drugs), By Therapy Type (Chemotherapy, Targeted Therapy, and Immunotherapy), By Cancer Type (Lung Cancer, Breast Cancer, Leukemia, and Colorectal Cancer), and Regional Forecasts 2020-2027  , Covid 19 Outbreak Impact research report added by Report Ocean, predicts the industry’s performance for the upcoming years to help stakeholders in making the right decisions that can potentially garner strong returns. Further, the document provides comprehensive analysis of the key industry trends as well as the opportunities that will ensure an upward growth trajectory in the coming years. It also focuses on developing strategies for challenges faced by the industry. Moreover, an exhaustive discussion of the latest updates including the impact of COVID-19 pandemic is furnished in the study. Get complete Report (Including Full TOC, 100+ Tables & Figures, and Chart). – In-depth Analysis Pre & Post COVID-19 Market Outbreak Impact Analysis & Situation by Region

Download Free Sample Copy of ‘Anticancer Drugs market’ Report @

Global Anticancer Drugs Market is valued approximately at USD 105.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2020-2027. Sales of anti-cancer drugs are gaining momentum, as many awareness campaigns are being undertaken at global level by governments and central authorities. The National Breast Cancer Foundation, Inc. is undertaking an annual initiative to promote information on the disease by observing October as a month of recognition of breast cancer and encouraging women to undergo screening tests. Such programs are rising the number of diagnostics, unwittingly creating a large patient pool for anticancer drugs. The increase in funding to promote research and development of anticancer therapy is contributing to improvements in treatment methods and routes of administration. The creation of therapies with improved patient outcomes and less side-effects than traditional drugs is expected to increase patient confidence in these drugs and thus improve the growth potential of the market for anticancer drugs. Besides, the U.S. The Food and Drug Administration (FDA) determines the status of ‘orphan drugs’ for drugs that have a promising potential for the treatment of rare diseases. In order to further encourage the production of highly successful medicines for rare diseases such as cancer, the FDA provides benefits such as market exclusivity and tax credits for clinical trials. In the background of these dynamics, the demand for and availability of these drugs is expected to increase, thereby boosting the growth of the global market for anticancer drugs. Anti-cancer drug market sales are projected to rise by 50% over the next five years, primarily due to favorable regulatory scenarios in the U.S. According to the American Cancer Society, the number of deaths worldwide was 8.2 billion in 2012 and is projected to rise over the predicted period. Despite a dramatic increase in cancer diagnosis rates, the sales of anticancer drugs have yet to recognize their true potential. Growing understanding of the side-effects of anticancer treatment, such as hair loss, anemia, constipation, infection and neutropenia, sexual health problems, and bleeding and bruising, is expected to raise the consumer’s inclination towards natural therapy. In regions such as Southeast Asia , the Middle East and Africa, India and China, patients are taking alternative therapeutic drugs such as Ayurveda, homoeopathic and herbal medicines, which could have a negative effect on the demand for anticancer drugs during the forecast period (2020-2027).

The regional analysis of global Anticancer Drugs Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is projected to grow at a rapid pace during the forecast period other than Japan and Australia, which appears to be favorable to business growth. Growing recognition of the advantages of early detection, growing disposable incomes, increasing prevalence of the number of types of cancer, and estimated pipeline drugs are driving the growth of the regional sector. Due to the easy availability of drugs in the region and high spending on healthcare from both the private and public sectors, North America is projected to make a major contribution to the global market for anti-cancer drugs. Apart from that, existing players are joining China and India because of the high prevalence of the market making it attractive. Markets in other regions, such as Africa , the Middle East and Latin America, are expected to expand at a moderate pace during the forecast period.

Major market player included in this report are:

  1. Hoffmann-La Roche Ltd

Eli Lilly and Company

Novartis AG

Pfizer Inc

Bayer AG


Takeda Pharmaceutical Company Limited

Merck & Co., Inc.


Amgen Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Cytotoxic Drugs

Targeted Drugs

Hormonal Drugs

By Therapy Type:


Targeted Therapy



By Cancer Type:

Lung Cancer

Breast Cancer


Colorectal Cancer


A combination of factors, including COVID-19 containment situation, end-use market recovery & Recovery Timeline of 2020/ 2021

covid-19 scenario

Market Behavior/ Level of Risk and Opportunity

End Industry Behavior/ Opportunity Assessment

Expected Industry Recovery Timeline

Business Impact Horizon

Opening of Economy by Q3 2020





Recovery – Opening of Economy extended till Q4 2020 / Q1 2021





Key highlights from COVID-19 impact analysis:

  • Predictions regarding long-term effects of COVID-19 pandemic on the growth trend.
  • Socio-economic implications of the coronavirus outbreak on the Market.
  • Peaks and valleys in demand during the Covid-19 lockdown period.
  • Supply chain challenges.
  • Projected long-term outlook of the pandemic on industry development.

For more information or any query mail at 

An overview of the regional landscape:

 The key regions covered in the report are North America, Europe, China, Japan and South Korea, It also covers key regions (countries), viz, the U,S,, Canada, Germany, France, U,K,, Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U,A,E, etc,.

 Regional contribution to the overall market growth is measured in the study.

 Revenue generated, sales garnered, and growth rate attained by each region during forecast period are cited.

The market growth is analyzed by studying multiple determinants such as:

  • Market Drivers
  • Market Trends
  • Market Challenges
  • Market Opportunities
  • Market Restraints, and
  • Market Competition

(Check Our Exclusive Offer: 30% to 40% Discount)

Key Questions Answered in The Report:

  • What will the Market growth rate?
  • What are the key factors driving the global Market?
  • Who are the key manufacturers in Market space?
  • What are the market opportunities and overview of the Market?
  • What are sales, revenue, and price analysis of top manufacturers of Market?
  • What are the Market opportunities and threats faced by the vendors in the global Market?
  • What are sales, revenue, and price analysis by types and applications of Market?

Inquire more and share questions if any before the purchase on this report at

Key Points Covered in Anticancer Drugs Market Report:

Chapter 1.      Executive Summary

1.1.       Market Snapshot

1.2.      Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1.   Anticancer Drugs Market, by Region, 2018-2027 (USD Billion)

1.2.2.   Anticancer Drugs Market, by Drug Type, 2018-2027 (USD Billion)

1.2.3.   Anticancer Drugs Market, by Therapy Type, 2018-2027 (USD Billion)

1.2.4.   Anticancer Drugs Market, by Cancer Type, 2018-2027 (USD Billion)

1.3.      Key Trends

1.4.      Estimation Methodology

1.5.      Research Assumption

Chapter 2.      Global Anticancer Drugs Market Definition & Scope

2.1.      Objective of the Study

2.2.      Market Definition & Scope

2.2.1.   Scope of the Study

2.2.2.  Industry Evolution

2.3.      Years Considered for the Study

2.4.      Currency Conversion Rates

Chapter 3.      Global Anticancer Drugs Market Dynamics     

3.1.      Anticancer Drugs Market Impact Analysis (2018-2027)

3.1.1.   Market Drivers

3.1.2.   Market Challenges

3.1.3.   Market Opportunities

Chapter 4.      Global Anticancer Drugs Market: Industry Analysis

4.1.      Porter’s 5 Force Model

4.1.1.   Bargaining Power of Suppliers

4.1.2.   Bargaining Power of Buyers

4.1.3.   Threat of New Entrants

4.1.4.   Threat of Substitutes

4.1.5.   Competitive Rivalry

4.1.6.   Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2.      PEST Analysis

4.2.1.   Political

4.2.2.  Economical

4.2.3.  Social

4.2.4.  Technological

4.3.      Investment Adoption Model

4.4.      Analyst Recommendation & Conclusion

Chapter 5.      Global Anticancer Drugs Market, by Drug Type

5.1.      Market Snapshot

5.2.      Global Anticancer Drugs Market by Drug Type, Performance – Potential Analysis

5.3.      Global Anticancer Drugs Market Estimates & Forecasts by Drug Type, 2017-2027 (USD Billion)

5.4.      Anticancer Drugs Market, Sub Segment Analysis

5.4.1.   Cytotoxic Drugs

5.4.2.   Targeted Drugs

5.4.3.   Hormonal Drugs

Chapter 6.      Global Anticancer Drugs Market, by Therapy Type

6.1.      Market Snapshot

6.2.      Global Anticancer Drugs Market by Therapy Type, Performance – Potential Analysis

6.3.      Global Anticancer Drugs Market Estimates & Forecasts by Therapy Type, 2017-2027 (USD Billion)

6.4.      Anticancer Drugs Market, Sub Segment Analysis

6.4.1.   Chemotherapy

6.4.2.  Targeted Therapy

6.4.3.  Immunotherapy

6.4.4.  Others

Chapter 7.      Global Anticancer Drugs Market, by Cancer Type

7.1.      Market Snapshot

7.2.      Global Anticancer Drugs Market by Cancer Type, Performance – Potential Analysis

7.3.      Global Anticancer Drugs Market Estimates & Forecasts by Cancer Type, 2017-2027 (USD Billion)

7.3.1.   Lung Cancer

7.3.2.   Breast Cancer

7.3.3.   Leukaemia

7.3.4.   Colorectal Cancer

7.3.5.   Others

Chapter 8.     Global Anticancer Drugs Market, Regional Analysis

8.1.      Anticancer Drugs Market, Regional Market Snapshot

8.2.     North America Anticancer Drugs Market

8.2.1.   U.S.  Anticancer Drugs Market            Drug Type breakdown estimates & forecasts, 2017-2027           Therapy Type breakdown estimates & forecasts, 2017-2027           Cancer Type breakdown estimates & forecasts, 2017-2027

8.2.2.  Canada Anticancer Drugs Market

8.3.     Europe Anticancer Drugs Market Snapshot

8.3.1.   U.K.  Anticancer Drugs Market

8.3.2.  Germany Anticancer Drugs Market

8.3.3.  France Anticancer Drugs Market

8.3.4.  Spain Anticancer Drugs Market

8.3.5.  Italy Anticancer Drugs Market

8.3.6.  Rest of Europe Anticancer Drugs Market

8.4.     Asia-Pacific Anticancer Drugs Market Snapshot

8.4.1.   China Anticancer Drugs Market

8.4.2.  India Anticancer Drugs Market

8.4.3.  Japan Anticancer Drugs Market

8.4.4.  Australia Anticancer Drugs Market

8.4.5.  South Korea Anticancer Drugs Market

8.4.6.  Rest of Asia Pacific Anticancer Drugs Market

8.5.      Latin America Anticancer Drugs Market Snapshot

8.5.1.   Brazil Anticancer Drugs Market

8.5.2.  Mexico Anticancer Drugs Market

8.6.     Rest of The World Anticancer Drugs Market

Chapter 9.      Competitive Intelligence

9.1.      Top Market Strategies

9.2.      Company Profiles

9.2.1.   F. Hoffmann-La Roche Ltd            Key Information            Overview            Financial (Subject to Data Availability)            Industry Summary            Recent Developments

9.2.2.  Eli Lilly and Company

9.2.3.  Novartis AG

9.2.4.  Pfizer Inc

9.2.5.   Bayer AG

9.2.6.  AstraZeneca

9.2.7.   Takeda Pharmaceutical Company Limited

9.2.8.  Merck & Co., Inc.


9.2.10.            Amgen Inc

Chapter 10.    Research Process

10.1.    Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2.    Research Attributes

10.3.    Research Assumption

……..and view more in complete table of Contents

Browse Premium Research Report with Tables and Figures at @

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.

Tags: , , , , , , , , , ,

See Campaign:
Contact Information:
Report Ocean
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)

, IPS, Reportedtimes, iCN Internal Distribution, Research Newswire, English


Contact Information:

Report Ocean
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)